Legacy Education Inc. reported revenue of $19.2 million for the quarter ended December 31, 2025, a 40.7% increase from the $13.6 million earned in the same period a year earlier. The jump was driven by a 49.4% rise in new student starts and a 16.8% increase in total enrollment, reflecting sustained demand for the company’s healthcare‑focused programs.
Net income rose to $2.0 million, up from $1.4 million in Q2 2025, while earnings per share climbed to $0.15 from $0.10. The $0.15 EPS beat the consensus estimate of $0.13 by $0.02, a 15% lift, as higher‑margin program enrollment and disciplined cost management offset the absence of revenue in the same quarter last year.
New student starts reached 593, a 49.4% increase year‑over‑year, and the ending student population grew to 3,234, up 16.8% from 2,700 in Q2 2025. The surge in starts is largely attributable to the expansion of MRI, cardiac sonography, and surgical technology programs, which have higher tuition rates and stronger placement outcomes.
CEO LeeAnn Rohmann said the company delivered "exceptional execution" in the quarter ended December 31, 2025, citing continued demand for healthcare education and Legacy's focus on "scaling quality" and training "job‑ready graduates." CFO Brandon Pope noted that revenue per student appears higher this quarter due to the absence of revenue in the same quarter last year, and that the company is seeing more starts in higher‑margin programs.
Analysts had projected revenue of $17.91 million and EPS of $0.13 for the quarter. Legacy’s results exceeded both estimates, with revenue beating expectations by $1.29 million (7.2%) and EPS surpassing the consensus by $0.02 (15%). The company’s ability to grow revenue while maintaining a healthy margin signals strong operational execution.
Investors remained cautious after the release, focusing on valuation multiples and the company’s guidance for the remainder of the fiscal year. Management indicated confidence in continued enrollment growth and hinted at a potential acquisition before year‑end, suggesting a strategic push to expand its footprint in the healthcare education market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.